Cardiovascular diseases (CVDs) are one of the most cause of death around the world and fields of interest for cardiac stem cells. Also, current use of terminally differentiated adult cardiomyocytes for CVDs has limited regenerative capacity therefore any significant cell loss may result in the development of progressive heart failure. Human embryonic stem cells (hESCs) derived from blastocyst‐stage embryos spontaneously have ability to differentiate via embryo‐like aggregates (endoderm, ectoderm and mesoderm) in vitro into various cell types including cardiomyocyte. However, most effective molecule or optimized condition which can induce cardiac differentiation of hESCs is rarely studied. In this study, we developed both spontaneous and inductive cardiomyocyte‐like cells differentiation from hESCs by treatment of induced‐factors, 5‐azacytidine, BMP‐4 and cardiogenol C. On the one hand, spontaneous and inductive cardiomyocyte‐like cells showed that cardiac markers are expressed for further analysis by RT‐PCR and immunocytochemistry. Interestingly, BMP‐4 greatly improved mogeneous population of the cardiomyocyte‐like cells from hESCs CHA15 and H09. In conclusion, we verified that spontaneously differentiated cells showed cardiac specific markers which characterize cardiac cells, treated extrinsic factors can manage cellular signals and found that hESCs can undergo differentiation into cardiomyocytes better than spontaneous group. This finding offers an insight into the inductive factor of differentiated cardiomyocytes and provides some helpful information that may offer the potential of cardiomyocytes derived from hESCs using extrinsic factors.
목차
ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
키워드
hESCCardiomyocyteDifferentiationBMP‐4
저자
Chang-Hyun Gil [ Graduate School of Life Science, CHA Stem Cell Institute, College of Medicine, CHA University ]
Jae-Woo Jang [ Graduate School of Life Science, CHA Stem Cell Institute, College of Medicine, CHA University ]
Won-Young Lee [ CHA Bio & Diostech Co., Ltd. ]
Ze-Won Park [ Graduate School of Life Science, CHA Stem Cell Institute, College of Medicine, CHA University ]
Jae-Ho Lee [ CHA Bio & Diostech Co., Ltd. ]
Sun-Hwa Chung [ Graduate School of Life Science, CHA Stem Cell Institute, College of Medicine, CHA University ]
Jung-Il Chae [ Graduate School of Life Science, CHA Stem Cell Institute, College of Medicine, CHA University ]
Hyung-Min Chung [ Graduate School of Life Science, CHA Stem Cell Institute, College of Medicine, CHA University, CHA Bio & Diostech Co., Ltd. ]
Corresponding author